MAY 05, 2017 8:41 AM PDT

'Exercise-in-a-pill' boosts stamina in mice

WRITTEN BY: Xuan Pham

Is it possible to bypass countless hours of endurance training by popping a stamina pill? Recent research in mouse studies suggest that stamina can be captured in chemical form and ingested for serious results. How’s that for instant gratification?

Image credit: wikipedia.org

Marathon runners and long-distance cyclists are renowned for their unending endurance. Years of rigorous training transformed these athletes’ muscles to burn more fat while reserving glucose for the brain. This is how the athletes minimize fatigue, which is caused by the depletion of glucose supply to the brain.

The drug, called GW1516, was develped in the 1990s for the treatment of metabolic and cardiovascular diseases. Then in 2007, the first studies hinted at the drug's ability to boost physical performance in mice. With more recent investigations, scientists found that the drug increases stamina by willing the muscles to burn more fat while leaving the glucose supply alone. In mouse studies, sedentary animals that were given GW1516 for eight weeks were able to outrun control animals by 110 minutes on a treadmill before showing signs of fatigue. That’s mighty impressive considering that the average person can typically run for 15 to 30 minutes before getting winded.

The chemical affected a vast network of 975 genes. Genes that increased fat metabolism were upregulated while genes that promote the breakdown of glucose were uncharacteristically silenced.

"If you reprogram the genetics, you can acquire that level of fitness without having to expend a lot of energy," said Ronald Evans, the study’s author.

Evans noted that the increased stamina was not a result of new muscle biology. "What's interesting to me here is that there is no change in fiber type or mitochondrial content, and that the improvement in endurance from GW1516 is primarily, or overwhelmingly, due to differences in glucose management," said Evan Williams, a scientist unassociated with the current study.

While the results seem promising, it’s important to remember that the results were obtained in mice. There’s no telling if the drug will behave the same when tested in human subjects. And the researchers may have difficulty getting that sort of clinical trial underway, at least in the US, since GW1516 is, ultimately, a performance enhancing drug. On the black market, GW1516 is known as Endurobol.

 

"That doesn't mean we shouldn't develop the drug for the people who need it," said Evans. He encouraged that the drug be viewed beyond the scope of athletics. Rather, if we view the drug from the perspective of the elderly or those who have physical limitations, the drug could be life-changing. But so far, the manufacture of the drug is currently restricted to Russia; the team will have to show deeper evidence of the drug’s benefits to human health in the near future.

Additional source: Live Science

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 15, 2021
Clinical & Molecular DX
A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Tests
APR 15, 2021
A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Tests
Duke University scientists have created a highly sensitive Ebola virus portable diagnostic device, 1000 times more sensi ...
APR 20, 2021
Cardiology
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
APR 20, 2021
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
Diabetes is a looming threat to the world’s healthcare systems. Diagnoses of its precursors, impaired glucose tole ...
MAY 11, 2021
Clinical & Molecular DX
Every Minute Counts: Opportunities for Faster Blood Culture Results
MAY 11, 2021
Every Minute Counts: Opportunities for Faster Blood Culture Results
Sepsis is one of the most significant challenges in critical care, and early diagnosis is a decisive factor in determini ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUL 27, 2021
Clinical & Molecular DX
Thumb-Sized Device Tells You if Your Breath Stinks
JUL 27, 2021
Thumb-Sized Device Tells You if Your Breath Stinks
People generally can’t smell their own breath. So, for individuals with halitosis—or bad breath—friend ...
AUG 15, 2021
Microbiology
Lyme Disease Linked to Significantly Increased Suicide Risk
AUG 15, 2021
Lyme Disease Linked to Significantly Increased Suicide Risk
While about 30,000 cases of Lyme disease are reported to the CDC every year, the disease has been estimated to cause abu ...
Loading Comments...